Hwan-Mook Kim Selected Research

Hwan-Mook Kim Research Topics

Disease

24	Neoplasms (Cancer) 09/2015 - 03/2002
3	Colorectal Neoplasms (Colorectal Cancer) 09/2015 - 09/2008
3	Colonic Neoplasms (Colon Cancer) 04/2015 - 02/2010
3	Carcinoma (Carcinomatosis) 12/2013 - 02/2004
2	Leukemia 03/2019 - 02/2010
2	Carcinogenesis 06/2011 - 10/2010
2	Hypoxia (Hypoxemia) 10/2010 - 03/2010
1	Neoplastic Cell Transformation 07/2014
1	Breast Neoplasms (Breast Cancer) 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Brain Neoplasms (Brain Tumor) 02/2012
1	Glioblastoma (Glioblastoma Multiforme) 02/2012
1	Body Weight (Weight, Body) 06/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011
1	Dyslexia (Alexia) 01/2011
1	Neoplasm Metastasis (Metastasis) 03/2010
1	Inflammation (Inflammations) 09/2008
1	Stomach Neoplasms (Stomach Cancer) 09/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2006
1	Asthma (Bronchial Asthma) 01/2006
1	Experimental Melanoma 02/2005
1	Adenocarcinoma 05/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2004
1	Lung Neoplasms (Lung Cancer) 01/2004
1	Melanoma (Melanoma, Malignant) 01/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2019 - 02/2004
6	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011 - 01/2003
3	Pharmaceutical PreparationsIBA 04/2015 - 02/2004
3	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 03/2002
3	TransferasesIBA 04/2006 - 02/2004
2	Histone Deacetylase InhibitorsIBA 07/2014 - 09/2008
2	anthraceneIBA 05/2010 - 08/2008
2	2'-benzoyloxycinnamaldehydeIBA 01/2006 - 02/2004
1	Histones (Histone)IBA 03/2019
1	Lysine (L-Lysine)FDA Link 03/2019
1	MethyltransferasesIBA 03/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015
1	Neutralizing AntibodiesIBA 09/2015
1	CG100649IBA 04/2015
1	TNF-Related Apoptosis-Inducing LigandIBA 04/2015
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2015
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2015
1	Epidermal Growth Factor (EGF)IBA 07/2014
1	4- hexadecanoyl- 1,1- dimethylpiperazin- 1- iumIBA 01/2014
1	BromidesIBA 12/2013
1	GinsenosidesIBA 07/2013
1	protopanaxadiolIBA 07/2013
1	Tuberculin (PPD)IBA 07/2013
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 07/2013
1	LipidsIBA 07/2013
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	hydrogen sulfite (bisulfite)IBA 04/2012
1	RolipramIBA 02/2012
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 02/2012
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2012
1	Phosphodiesterase InhibitorsIBA 02/2012
1	N- cyclohexyl- 6- (2- oxo- 4- phenylimidazolidin- 1- ylsulfonyl)- 3,4- dihydroquinoline- 1(2H)- carboxamideIBA 08/2011
1	N- (2- chloroacetyl)- 6- (2- oxo- 4- phenylimidazolidin- 1- ylsulfonyl)- 3,4- dihydroquinoline- 1(2H)- carboxamideIBA 08/2011
1	Niacinamide (Nicotinamide)FDA LinkGeneric 06/2011
1	NitrosaminesIBA 06/2011
1	Antineoplastic Agents (Antineoplastics)IBA 06/2011
1	Therapeutic UsesIBA 06/2011
1	ChromatinIBA 06/2011
1	CarcinogensIBA 06/2011
1	RNA Precursors (Precursor, mRNA)IBA 01/2011
1	titanium dioxide (Titania)FDA Link 01/2011
1	Cholecalciferol (Vitamin D3)FDA Link 10/2010
1	Cell Cycle ProteinsIBA 10/2010
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2010
1	Hypoxia-Inducible Factor 1IBA 03/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2010
1	Ether (Diethyl Ether)IBA 02/2010
1	LignansIBA 09/2008
1	obovatolIBA 09/2008
1	Biological ProductsIBA 09/2008
1	honokiolIBA 09/2008
1	magnololIBA 09/2008
1	Decitabine FDA Link 09/2008
1	Leucine (L-Leucine)FDA Link 09/2008
1	trichostatin A (A 300)IBA 09/2008
1	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 10/2007
1	Dihydrotachysterol (AT 10)IBA 04/2006
1	AlbuminsIBA 01/2006
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	Terminator Codon (Termination Codon)IBA 01/2006
1	B-Cell Activating FactorIBA 01/2006
1	Immunoglobulin E (IgE)IBA 01/2006
1	Caspase 3 (Caspase-3)IBA 11/2005
1	methyllucidoneIBA 11/2005
1	Polysaccharides (Glycans)IBA 02/2005
1	GlucansIBA 02/2005
1	indolineIBA 05/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2004

Therapy/Procedure

2	Therapeutics 10/2010 - 02/2004
1	Drug Therapy (Chemotherapy) 07/2013
1	Immunomodulation 01/2011